Indan-5-amine → HCID 136337178, Verbindung
Reaktionsgleichung
C1C2C(=CC(N)=CC=2)CC1.[CH2:11]([O:13][C:14]([C:16]1[CH:17]=[N:18][N:19]([C:21]2[NH:30][C:29](=[O:31])[C:28]3[C:27]4[CH2:32][CH2:33][CH2:34][C:26]=4[CH:25]=[CH:24][C:23]=3[N:22]=2)[CH:20]=1)=[O:15])[CH3:12]>>[CH2:11]([O:13][C:14]([C:16]1[CH:17]=[N:18][N:19]([C:21]2[NH:30][C:29](=[O:31])[C:28]3[C:23](=[CH:24][C:25]4[CH2:32][CH2:33][CH2:34][C:26]=4[CH:27]=3)[N:22]=2)[CH:20]=1)=[O:15])[CH3:12]Komponenten
3
Versuchsvorschrift
The titled compound was prepared in a manner analogous to Example 131, steps A-B, using indan-5-ylamine in step A. Step B yielded a 10:1 mixture of the titled compound and 1-(1-oxo-2,7,8,9-tetrahydro-1H-cyclopenta[f]quinazolin-3-yl)-1H-pyrazole-4-carboxylic acid ethyl ester.
Aufarbeitung
- customThe titled compound was prepared in a manner analogous to Example 131, steps A-B
- customStep B yielded
Quellen und Nachweise
- ORD-Eintrag
- ord-bea0d73b47a947b294bec0980bd72683
- Quelldatensatz
- uspto-grants-2015_01
- Patentnummer
- US08937078B2
Notizen zur Reaktion
Wird geladen…